Company Information
- CEO
- Michael Pragnell
- Investor Relations
- Richard Steiblin
Syngenta AG is formed from Novartis and Zeneca an agribusiness company operating across all major areas of crop protection and seed with products designed to improve crop yields and food quality.
Trading Information
- Sector
- Chemicals - 1300
- Regulatory Standard
- International Reporting Standard
- Security Number
- 1103746
- ISIN
- CH0011037469
- Symbol
- SYNN
- Index member
- SPI, SMI
Intermediaries
- Listing Agent
-
Credit Suisse First Boston,
UBS Warburg - Lead Bank
- Credit Suisse First Boston & UBS Warburg
- Auditor
- PriceWaterhouseCoopers AG
Information on the Issue
| Security Details | |
|---|---|
| First Listing | 13.11.2000 |
| Class of Share | Action nominative |
| Nominal Value | 10.00 CHF |
| Total Shares outstanding (post issue; incl. Greenshore - if any) | 112564584 |
| Allocation Details | |
|---|---|
| Primary Shares | n/a |
| Secondary Shares | 4500000 |
| Primary Greenshoe | n/a |
| Secondary Greenshoe | n/a |
| Greenshoe Details | |
|---|---|
| Executed | no GS at all |
| Ex-date | n/a |
| Executed number of shares | n/a |
| First Trading Day Details | |
|---|---|
| First Trading | 13.11.2000 |
| Price Range | n/a |
| Issue Price | 85.00 CHF |
| First Open | 75.00 CHF |
| First Close | 79.50 CHF |
| Transaction size in Mio. (incl. executed Greenshoe) | 382.5 CHF |
| Market Capitalisation in Mio. (based on first closing price) | 8948.9 CHF |
Financial Statement
| Number of Employees | n/a |
| Net Revenues in Mio. | 6846 USD 2000 |
| Net Gain in Mio. | n/a |